-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse NYSE New York Stock Exchange
Doximity, Inc. outperformed den DAX um +78 % vom 24.06.2021 bis 14.09.2021
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Dir gefallen die Informationen zu Doximity, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Doximity, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Doximity, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Doximity, Inc.?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
23 News & Informationen zur Doximity, Inc. Aktie
US stock markets mixed, inflation disappoints
It was another broadly positive day for the US stock markets with the Nasdaq the only detractor.
48 Stocks Moving In Wednesday's Mid-Day Session
Gainers Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) gained 82% to $25.19. The company, last month, priced its IPO at $11 per share. CohBar, I…
Doximity : Announces Fiscal 2022 First Quarter Financial Results
SAN FRANCISCO, Aug. 10, 2021 /PRNewswire/ — Doximity, Inc. , the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2022 first quarter ended… | August 10, 2021
Doximity Announces Fiscal 2022 First Quarter Financial Results
/PRNewswire/ — Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results for the fiscal 2022 first…
The social network for doctors is full of vaccine disinformation
Doctors are surprised to find anti-vaccine posts proliferating on Doximity, a professional network for physicians.
Is This New Healthcare IPO Worth the Hype?
Doximity went public last month, and it is already trading at a steep price tag.
Changes to our portfolio and why. A 29-year old worth $8 billion. Dehydration is the worst. It can happen to any of us. « In Search of the Perfect Investment
1 Recent Healthcare IPO to Put on Your Radar
This app for healthcare professionals could be an interesting investment.
Better Healthcare Stock: Teladoc vs. Doximity
Teladoc Health was the first mover, but it's no longer top dog by some standards.
Doximity (DOCS): Hot IPO, Valuation And Profitability Leave Upside For Potential Investors
Doximity is a recent hot IPO whose valuation has doubled since its recent IPO. The company has developed a platform that counts more than 80% of US physicians as members.
Dollar Cost Averaging Revisited. Federer’s devilish squash shot. Critical issues — like hearing aids — solved. The simplest best software. « In Search of the Perfect Investment
2 New IPOs With Explosive Potential
Stocks Analysis by MarketBeat.com (Sean Sechler) covering: Crowdstrike Holdings Inc, Doximity Inc, SentinelOne Inc. Read MarketBeat.com (Sean Sechler)'s latest article on Investing.com
4 Overvalued Healthcare Stocks to Avoid By StockNews
4 Overvalued Healthcare Stocks to Avoid
Startups cash in as venture funding for digital health rises
Startups Cash In as Venture Funding for Digital Health Rises
Doximity (DOCS) Stock: Should You Buy This Recent IPO?
Doximity was listed on the NYSE on June 24, 2021, and its last traded price is still close to double that of its IPO price. Find out if DOCS stock is a buy.
Does Etsy's Elo7 Deal Make Sense?
Etsy's strategy for conquering this market in Latin America.
MarketBeat Ranks Stocks with Most Insider Buying in June 2021
Sioux Falls, SD (PRWEB) July 08, 2021 — MarketBeat, a leading source for stock market data and research tools, has published a monthly list ranking The 10
The 10 Stocks With The Most Insider Buying In June 2021
Stocks Analysis by MarketBeat.com (Chris Markoch) covering: Amerco, Hudson Ltd, Hudson Executive Investment Corp, ARYA Sciences Acquisition Corp. Read MarketBeat.com (Chris Markoch)'s latest article on Investing.com
Notable Insider Buys In The Past Week: Asana, Transocean, IPOS, SPACS And More
Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. A couple of special purpose…
I'm Buying Doximity Stock, But Not For A While (NYSE:DOCS)
Doximity, sometimes known as the LinkedIn for doctors, IPO'd recently, and the share price jumped.
Worries emerge about the Delta variant and the J&J shot. But health officials and preliminary research say the vaccinated are still protected
The Delta variant is already the most dominant strain of the virus in some U.S. states, and that’s putting some Americans easing back into “normal” life on…
Blockbuster IPO day produces big gains for Uber, Delta Air Lines and tech VCs
With Didi, SentinelOne, CLEAR and LegalZoom debuting on Wednesday, strategic investors, venture capitalists and private equity firms shared in the wealth.
Doximity’s IPO Mints A New Healthcare Billionaire
Jeff Tangney, cofounder and CEO of the ‘LinkedIn For Doctors,’ owns a 32.9% stake, bringing his net worth to $2.8 billion.